The DOI matches its Crossref record; 89 of the 89 references it cites were found in a registry or an index.
Nanomedicine for drug delivery and imaging: A promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles
Abstract
The diagnosis and treatment of cancer or tumor at the cellular level will be greatly improved with the development of techniques that enable the delivery of analyte probes and therapeutic agents into cells and cellular compartments. Organic and inorganic nanoparticles that interface with biological systems have recently attracted widespread interest in the fields of biology and medicine. The new term nanomedicine has been used recently. Nanoparticles are considered to have the potential as novel intravascular or cellular probes for both diagnostic (imaging) and therapeutic purposes (drug/gene delivery), which is expected to generate innovations and play a critical role in medicine. Target‐specific drug/gene delivery and early diagnosis in cancer treatment is one of the priority research areas in which nanomedicine will play a vital role. Some recent breakthroughs in this field recently also proved this trend. Nanoparticles for drug delivery and imaging have gradually been developed as new modalities for cancer therapy and diagnosis. In this article, we review the significance and recent advances of gene/drug delivery to cancer cells, and the molecular imaging and diagnosis of cancer by targeted functional nanoparticles. © 2007 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toxic potential of materials at the nanolevel
Nel, A., Xia, T., Mädler, L., & Li, N. (2006) · Science · doi:10.1126/science.1114397 · Cited by 9,324
Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles
Oberdörster, G., Oberdörster, E., & Oberdörster, J. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7339 · Cited by 7,891
Quantum Dots for Live Cells, in Vivo Imaging, and Diagnostics
Michalet, X., Pinaud, F. F., Bentolila, L. A., Tsay, J. M., Doose, S., Li, J. J., Sundaresan, G., Wu, A. M., Gambhir, S. S., & Weiss, S. (2005) · Science · doi:10.1126/science.1104274 · Cited by 7,790
Quantum Dot Bioconjugates for Ultrasensitive Nonisotopic Detection
Chan, W. C. W., & Nie, S. (1998) · Science · doi:10.1126/science.281.5385.2016 · Cited by 7,278
Quantum dot bioconjugates for imaging, labelling and sensing
Medintz, I. L., Uyeda, H. T., Goldman, E. R., & Mattoussi, H. (2005) · Nature Materials · doi:10.1038/nmat1390 · Cited by 6,229
In vivo cancer targeting and imaging with semiconductor quantum dots
Gao, X., Cui, Y., Levenson, R. M., Chung, L. W. K., & Nie, S. (2004) · Nature Biotechnology · doi:10.1038/nbt994 · Cited by 4,772
Drug Delivery Systems: Entering the Mainstream
Allen, T. M., & Cullis, P. R. (2004) · Science · doi:10.1126/science.1095833 · Cited by 4,552
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
Panyam, J., & Labhasetwar, V. (2003) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00228-4 · Cited by 3,361
Nanoparticles in cancer therapy and diagnosis
Brigger, I., Dubernet, C., & Couvreur, P. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00044-3 · Cited by 3,039
Wu, X., Liu, H., Liu, J., Haley, K. N., Treadway, J. A., Larson, J. P., Ge, N., Peale, F., & Bruchez, M. P. (2003) · Nature Biotechnology · doi:10.1038/nbt764 · Cited by 2,506
Cited by
Nanoparticles in Medicine: Therapeutic Applications and Developments
Zhang, L., Gu, F., Chan, J., Wang, A., Langer, R., & Farokhzad, O. (2008) · Clinical Pharmacology & Therapeutics · doi:10.1038/sj.clpt.6100400 · Cited by 2,657
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Nanomaterials: Applications in Cancer Imaging and Therapy
Barreto, J. A., O’Malley, W., Kubeil, M., Graham, B., Stephan, H., & Spiccia, L. (2011) · Advanced Materials · doi:10.1002/adma.201100140 · Cited by 907
Current advances in research and clinical applications of PLGA-based nanotechnology
Lü, J.-M., Wang, X., Marin-Muller, C., Wang, H., Lin, P. H., Yao, Q., & Chen, C. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.15 · Cited by 903
Mahapatro, A., & Singh, D. K. (2011) · Journal of Nanobiotechnology · doi:10.1186/1477-3155-9-55 · Cited by 685
Assessing the In Vitro and In Vivo Toxicity of Superparamagnetic Iron Oxide Nanoparticles
Mahmoudi, M., Hofmann, H., Rothen-Rutishauser, B., & Petri-Fink, A. (2012) · Chemical Reviews · doi:10.1021/cr2002596 · Cited by 617
Magnetite nanoparticles for cancer diagnosis, treatment, and treatment monitoring: recent advances
Revia, R. A., & Zhang, M. (2016) · Materials Today · doi:10.1016/j.mattod.2015.08.022 · Cited by 612
PEGylated Inorganic Nanoparticles
Karakoti, A. S., Das, S., Thevuthasan, S., & Seal, S. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201002969 · Cited by 551
PLGA-Based Nanoparticles as Cancer Drug Delivery Systems
Tabatabaei Mirakabad, F. S., Nejati-Koshki, K., Akbarzadeh, A., Yamchi, M. R., Milani, M., Zarghami, N., Zeighamian, V., Rahimzadeh, A., Alimohammadi, S., Hanifehpour, Y., et al. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.2.517 · Cited by 542
Noble Metal Nanoparticles Applications in Cancer
Conde, J., Doria, G., & Baptista, P. (2012) · Journal of Drug Delivery · doi:10.1155/2012/751075 · Cited by 541
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Cheng, Y., Zhao, L., Li, Y., & Xu, T. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00097c · Cited by 515
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Majumder, J., & Minko, T. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00532-2 · Cited by 505
Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects
Kunjachan, S., Ehling, J., Storm, G., Kiessling, F., & Lammers, T. (2015) · Chemical Reviews · doi:10.1021/cr500314d · Cited by 480
Nanoparticles: Taking a Unique Position in Medicine
Joseph, T., Kar Mahapatra, D., Esmaeili, A., Piszczyk, Ł., Hasanin, M., Kattali, M., Haponiuk, J., & Thomas, S. (2023) · Nanomaterials · doi:10.3390/nano13030574 · Cited by 480
Conde, J., Oliva, N., Zhang, Y., & Artzi, N. (2016) · Nature Materials · doi:10.1038/nmat4707 · Cited by 449
In Vivo Targeted Delivery of Nanoparticles for Theranosis
Koo, H., Huh, M. S., Sun, I.-C., Yuk, S. H., Choi, K., Kim, K., & Kwon, I. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000138 · Cited by 447
Liang, C., Xu, L., Song, G., & Liu, Z. (2016) · Chemical Society Reviews · doi:10.1039/c6cs00458j · Cited by 435
El-Sawy, H. S., Al-Abd, A. M., Ahmed, T. A., El-Say, K. M., & Torchilin, V. P. (2018) · ACS Nano · doi:10.1021/acsnano.8b06104 · Cited by 431
Paclitaxel: What has been done and the challenges remain ahead
Bernabeu, E., Cagel, M., Lagomarsino, E., Moretton, M., & Chiappetta, D. A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.05.016 · Cited by 413
Inorganic Nanoparticles in Cancer Therapy
Bhattacharyya, S., Kudgus, R. A., Bhattacharya, R., & Mukherjee, P. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0318-0 · Cited by 395
Recent advances in dendrimer-based nanovectors for tumor-targeted drug and gene delivery
Kesharwani, P., & Iyer, A. K. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.12.012 · Cited by 380
Knopp, D., Tang, D., & Niessner, R. (2009) · Analytica Chimica Acta · doi:10.1016/j.aca.2009.05.037 · Cited by 380
Brandenberger, C., Mühlfeld, C., Ali, Z., Lenz, A., Schmid, O., Parak, W. J., Gehr, P., & Rothen‐Rutishauser, B. (2010) · Small · doi:10.1002/smll.201000528 · Cited by 355
Recent advances in metal nanoparticles in cancer therapy
Sharma, A., Goyal, A. K., & Rath, G. (2018) · Journal of Drug Targeting · doi:10.1080/1061186x.2017.1400553 · Cited by 341
PLGA-based nanoparticles: A new paradigm in biomedical applications
Sharma, S., Parmar, A., Kori, S., & Sandhir, R. (2016) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2015.06.014 · Cited by 340
Unveiling in Vivo Subcutaneous Thermal Dynamics by Infrared Luminescent Nanothermometers
Ximendes, E. C., Santos, W. Q., Rocha, U., Kagola, U. K., Sanz-Rodríguez, F., Fernández, N., Gouveia-Neto, A. D. S., Bravo, D., Domingo, A. M., del Rosal, B., et al. (2016) · Nano Letters · doi:10.1021/acs.nanolett.5b04611 · Cited by 325
Molecular Nanomedicine Towards Cancer: 111In-Labeled Nanoparticles
Psimadas, D., Georgoulias, P., Valotassiou, V., & Loudos, G. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23146 · Cited by 322
Gold nanoparticles in cancer therapy
Lim, Z.-Z. J., Li, J.-E. J., Ng, C.-T., Yung, L.-Y. L., & Bay, B.-H. (2011) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.82 · Cited by 314
Hwang, D. W., Ko, H. Y., Lee, J. H., Kang, H., Ryu, S. H., Song, I. C., Lee, D. S., & Kim, S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.069880 · Cited by 293
Bharadwaj, K. K., Rabha, B., Pati, S., Sarkar, T., Choudhury, B. K., Barman, A., Bhattacharjya, D., Srivastava, A., Baishya, D., Edinur, H. A., et al. (2021) · Molecules · doi:10.3390/molecules26216389 · Cited by 284
Toxicology of Nanomaterials Used in Nanomedicine
Zhao, J., & Castranova, V. (2011) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937404.2011.615113 · Cited by 280
Zhu, D., Tao, W., Zhang, H., Liu, G., Wang, T., Zhang, L., Zeng, X., & Mei, L. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.031 · Cited by 278
Mulder, W. J. M., Strijkers, G. J., van Tilborg, G. A. F., Cormode, D. P., Fayad, Z. A., & Nicolay, K. (2009) · Accounts of Chemical Research · doi:10.1021/ar800223c · Cited by 267
Application of Nanotechnology in Drug Delivery
(2014) · InTech eBooks · doi:10.5772/57028 · Cited by 266
Multifunctional dendrimer-entrapped gold nanoparticles for dual mode CT/MR imaging applications
Wen, S., Li, K., Cai, H., Chen, Q., Shen, M., Huang, Y., Peng, C., Hou, W., Zhu, M., Zhang, G., et al. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2012.11.010 · Cited by 257
Ray Chowdhuri, A., Bhattacharya, D., & Sahu, S. K. (2016) · Dalton Transactions · doi:10.1039/c5dt03736k · Cited by 253
Nanotechnology in Cancer Drug Delivery and Selective Targeting
Sutradhar, K. B., & Amin, M. L. (2014) · ISRN Nanotechnology · doi:10.1155/2014/939378 · Cited by 241
Multiple aspects of the interaction of biomacromolecules with inorganic surfaces
Fenoglio, I., Fubini, B., Ghibaudi, E. M., & Turci, F. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.08.001 · Cited by 176
Photodynamic therapy of lung cancer, where are we?
Crous, A., & Abrahamse, H. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.932098 · Cited by 38
Metadata
- Authors
- Liu, Y., Miyoshi, H., & Nakamura, M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2007-04-10
- Volume
- 120
- Issue
- 12
- Pages
- 2527-2537
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2015230924
- Cited by
- 620
- References
- 89
- FWCI
- 12.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.